TNDM — TANDEM DIABETES CARE INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1438133 ·
Last close
$17.06
Market Cap
$1.19B
52W High
$29.65
52W Low
$12.26
ADV30
2,596,201
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 283,690,000 | 160,422,000 | -2,369,000 | -7,085,000 | 1,159,494,000 | 72,840,000 | 1,024,407,000 |
| Jun 2026 | 254,560,000 | 144,780,000 | -13,792,000 | -21,168,000 | 1,154,202,000 | 62,818,000 | 1,023,814,000 |
| Mar 2026 | 247,221,000 | 136,788,000 | -17,434,000 | -20,393,000 | 1,153,394,000 | 179,325,000 | 1,020,991,000 |
| Dec 2025 | 290,383,000 | 167,460,000 | 8,294,000 | -589,000 | 881,112,000 | 90,634,000 | 725,942,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,523,000
Investing CF
$-277,224,000
Financing CF
$277,349,000
CapEx
$-56,219,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.93
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,294,096,000
Inventory
$135,106,000
Receivables
$162,065,000
ST Investments
$393,178,000
EBIT TTM
$-54,638,000
Pretax Income TTM
$-60,996,000
Interest Exp TTM
$6,358,000
Analysts
21
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,075,853,952
EBITDA
$-7,319,000
Free Cash Flow
$-65,562,376
Enterprise Value
$1,473,674,880
Total Cash
$443,081,984
Total Debt
$736,542,976
Shares Out
69,793,846
Trailing EPS
$-0.70
Book Value
$1.94
ROE
-36.7%
ROA
-1.6%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,014,736,000 | -167,306,000 | -204,710,000 | 881,112,000 | 725,942,000 | 155,170,000 | -9,721,000 |
| Dec 2024 | 940,203,000 | -99,127,000 | -96,025,000 | 967,658,000 | 704,560,000 | 263,098,000 | 24,225,000 |
| Dec 2023 | 747,718,000 | -233,230,000 | -222,611,000 | 952,658,000 | 639,026,000 | 313,632,000 | -31,810,000 |
| Dec 2022 | 801,217,000 | -92,848,000 | -94,594,000 | 1,052,785,000 | 612,838,000 | 439,947,000 | 50,464,000 |
TTM Snapshot
Revenues TTM
$1,041,417,000
NetIncome TTM
$-63,315,000
OpCashFlow TTM
—
Assets (Latest)
$1,154,202,000
Forward EPS
$0.17
Max Pain — expiry 2027-01-15
max pain strike: $21.00 · spot: $17.05 · call oi: 673 · put oi: 2,615
Expected Move to 2027-01-15:
±$6.30
(36.95%) —
implied range
$10.75 –
$23.35
· ATM straddle on $17.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DRTS | Alpha Tau Medical Ltd. | $1.12B | $12.09 | — |
| NVCR | NovoCure Ltd | $1.30B | $11.14 | — |
| IRMD | IRADIMED CORP | $1.07B | $83.45 | — |
| ATEC | Alphatec Holdings, Inc. | $1.06B | $6.94 | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.05B | $13.55 | — |
News headlines (Yahoo Finance, 1h cache)
Tandem Diabetes shares climb 5% after Stifel upgrades stock to Buy
2026-11-18 14:56 · Yahoo
Insulet downgraded, Tandem Diabetes upgraded: Wall Street's top analyst calls
2026-11-18 14:35 · Yahoo
Tandem wins FDA clearance for tubeless automated insulin delivery system
2026-11-16 11:48 · Yahoo
Tandem Diabetes stock jumps 8% on FDA clearance for tubeless pump
2026-11-13 15:11 · Yahoo
Can Tandem Diabetes Care (TNDM) Stay Cheap After Its Recall?
2026-11-13 09:10 · Yahoo
Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump
2026-11-12 13:30 · Yahoo
TNDM Q3 2026 deep dive: business model transition, product launches, and leadership change
2026-11-10 10:53 · Yahoo
Can Tandem Diabetes Care (TNDM) Justify Its Valuation As Q3 Earnings Beat And CEO Change Land?
2026-11-07 20:14 · Yahoo
What Tandem Diabetes Care (TNDM) Said on Its Q3 Earnings Call
2026-11-06 21:14 · Yahoo
Tandem Diabetes Care names next CEO
2026-11-06 15:36 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.